共 50 条
- [41] Phase II study of S-1 in combination with paclitaxel as a first-line treatment for patients with advanced/recurrent gastric cancerJOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (15)Toh, U.Yamana, H.Koufuji, K.Mine, T.Aoyagi, K.Miyagi, M.Imaizumi, T.Shirouzu, K.
- [42] Updated results of paclitaxel and cisplatin in combination with anlotinib as first-line treatment for patients with advanced ESCC: A multicenter, single-arm, open-label phase. clinical trial.JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 : 376 - 376Li, NingWu, TaoHong, Yong-GuiGuo, YanzhenCheng, YufengLi, BaoshengWang, JunshengLuo, Suxia
- [43] Anlotinib combined with penpulimab and nab-paclitaxel as first-line treatment for advanced esophageal squamous cell carcinoma (ESCC): A single-arm, open-label phase II clinical trialJOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (3_SUPPL) : 340 - 340Chang, ZhiweiLiu, Xiao-LeiYu, Dan-DanHan, Hui-QiongHe, JianWang, Rui-RuiQin, Yan-ru
- [44] First-line panitumumab combined with FOLFIRI for the treatment of patients with metastatic colorectal cancer (mCRC): data from a phase II, single-arm, multicentre study (20060314)ONKOLOGIE, 2010, 33 : 62 - 62Karthaus, M.Greil, R.Mineur, L.Letocha, H.Thaler, J.Hofheinz, R.Fernebro, E.Gamelin, E.DeCosta, L.Koehne, C.-H.
- [45] Skin toxicity and quality of life in patients with metastatic colorectal cancer during first-line panitumumab plus FOLFIRI treatment in a single-arm phase II studyBMC CANCER, 2012, 12Thaler, JosefKarthaus, MeinolfMineur, LaurentGreil, RichardLetocha, HenryHofheinz, RalfFernebro, EvaGamelin, ErickBanos, AnaKoehne, Claus-Henning
- [46] Skin toxicity and quality of life in patients with metastatic colorectal cancer during first-line panitumumab plus FOLFIRI treatment in a single-arm phase II studyBMC Cancer, 12Josef ThalerMeinolf KarthausLaurent MineurRichard GreilHenry LetochaRalf HofheinzEva FernebroErick GamelinAna BañosClaus-Henning Köhne
- [47] Fruquintinib with gefitinib as first-line therapy in patients carrying EGFR mutations with advanced non-small cell lung cancer: a single-arm, phase II studyTRANSLATIONAL LUNG CANCER RESEARCH, 2021, 10 (02) : 839 - +Lu, ShunZhou, Jian-YingNiu, Xiao-MinZhou, Jian-YaJian, HongYin, Hong-YanGuan, ShaWang, Lin-FangLi, KeHe, JamesSu, Wei-Guo
- [48] Phase II study of carboplatin followed by sequential gemcitabine and paclitaxel as first-line treatment for advanced ovarian cancerINTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2007, 17 (02) : 350 - 358Friedlander, M.Buck, M.Wyld, D.Findlay, M.Fitzharris, B.De Souza, P.Davies, T.Kalimi, G.Allan, S.Perez, D.Harnett, P.
- [49] Pazopanib for treatment of advanced extraskeletal myxoid chondrosarcoma: a multicentre, single-arm, phase 2 trialLANCET ONCOLOGY, 2019, 20 (09): : 1252 - 1262Stacchiotti, SilviaFerrari, StefanoRedondo, AndresHindi-Muniz, NadiaPalmerini, EmanuelaSalgado, Maria Angeles VazFrezza, Anna MariaCasali, Paolo GiovanniGutierrez, AntonioLopez-Pousa, AntonioGrignani, GiovanniItaliano, AntoineLeCesne, AxelDumont, SarahBlay, Jean YvesPenel, NicolasBernabeu, Danielde Alava, EnriqueKaranian, MarieMorosi, CarloBrich, SilviaDagrada, Gian PaoloVallacchi, VivianaCastelli, ChiaraBrenca, MonicaRacanelli, DomingoMaestro, RobertaCollini, PaolaCruz, JosefinaMartin-Broto, Javier
- [50] First-Line everolimus and cisplatin in patients with advanced extrapulmonary neuroendocrine carcinoma: a nationwide phase 2 single-arm clinical trialTHERAPEUTIC ADVANCES IN MEDICAL ONCOLOGY, 2022, 14Levy, SonjaVerbeek, Wieke H. M.Eskens, Ferry A. L. M.van den Berg, Jose G.de Groot, Derk Jan A.van Leerdam, Monique E.Tesselaar, Margot E. T.